4 Healthcare Stock Stories Ensuring Weekend Investment Wellness
GlaxoSmithKline plc (NYSE:GSK): Closing price $50.11 On Friday, GlaxoSmithKline and Genmab A/S announced the submission of a variation to the marketing authorization to the European Medicines Agency...
View ArticleAnalysts: Teva’s Outlook Gradually Improving and 3 Other Research Notes to...
Teva (NYSE:TEVA): After meeting with Teva line managers, Bernstein thinks the company will be able to reduce its costs by close to the promised $1.75 billion. The firm believes the company’s...
View ArticleMicrosoft Expedites CEO Search, Best Buy Moves On No News, and 3 More Hot Stocks
Microsoft Corp. (NASDAQ:MSFT): Microsoft is on the fast track to find a replacement CEO for Steve Ballmer, as the company hopes to appoint a new leader by the end of the year and is slimming down the...
View Article4 Healthcare Stock Stories for a Thursday Investment Checkup
Eli Lilly and Co. (NYSE:LLY): Closing price $49.14 The sixth Global Day of Service in Indianapolis will this year will include Lilly employees who will join thousands of other volunteers from local...
View Article4 Healthcare Stock Stories Getting Noticed on Monday
Merck & Co. (NYSE:MRK): Closing price $45.40 A type of HIV medicine that stops the AIDS virus from entering immune system cells might in the future be employed against cancer in new combination...
View ArticleSirius XM Brings Back Another Season of Coach K and 2 Other Hot Stocks to Watch
Sirius XM Radio Inc. (NASDAQ:SIRI): Current price $3.719 On Wednesday, Sirius XM Radio announced that Head Coach Mike Krzyzewski at Duke University and USA Men’s Basketball teams is coming back for a...
View ArticleAnalysts: GM’s Outlook Is Positive After Recent Reports and 3 More Research...
General Motors Vo. (NYSE:GM): General Motors has reported higher-than-expected earning per share ex-items but lower-than-expected revenue; RBC Capital believes the company’s North American division can...
View Article4 Healthcare Stock Stories to Start Off the Week’s Investment Wellness
Eli Lilly and Co. (NYSE: LLY): Closing price $50.17 On Monday, Goldman Sachs downgraded Eli Lilly from Neutral to Sell, and lowered its price target from $52 to $48. Analyst Jami Rubin recommended...
View ArticleSupreme Court Studies Generic Drug Question: How Will Patients Fare?
Source: http://www.flickr.com/photos/waywuwei/ Perhaps not as attention-grabbing as the health care industry’s struggle to adapt to the changes brought by the Affordable Care Act, its efforts to deal...
View Article3 Reasons to be Bullish on Teva Pharmaceutical
Source: Thinkstock Teva Pharmaceutical Inudstries Ltd. (NYSE:TEVA) has had a bit of a rough year so far: the first quarter of 2014 seems to have been primarily taken up by Teva’s attempts at winning...
View Article
More Pages to Explore .....